FMR1 mutant marmosets show fragile X syndrome phenotypes

Maria Harbers1, Zefeng Wei1, Harumi Nakao1

  • 1Laboratory of Animal Resources, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Cell Reports
|September 5, 2025
PubMed

Insights

Common marmosets with an FMR1 gene mutation offer a new model for Fragile X syndrome (FXS). These marmosets display FXS-like behaviors and molecular changes, aiding research into autism and intellectual disability.

Area of Science:

  • Neuroscience
  • Genetics
  • Primate Models

Background:

  • Fragile X syndrome (FXS) is a leading genetic cause of autism spectrum disorder and intellectual disability.
  • FXS results from the silencing of the FMR1 gene.

Purpose of the Study:

  • To establish and characterize common marmosets with an FMR1 mutation as a non-human primate model for FXS.
  • To investigate the behavioral and molecular phenotypes in marmosets carrying the FMR1 mutation.

Main Methods:

  • Generation of marmosets with FMR1 gene mutations.
  • Assessment of behavioral phenotypes including hyperactivity, seizures, vocal development, social preferences, and motor skills.
  • Analysis of molecular phenotypes, including transcriptome changes in synapse-related genes and electroencephalographic abnormalities.

Main Results:

  • Founder marmosets with reduced FMR1 expression exhibited hyperactivity, spontaneous seizures, and overlapping transcriptome changes with FXS patients.
  • GRM5 gene mutation rescued postnatal lethality in mutants, indicating mGluR5 signaling's role.
  • F1 heterozygous females showed FXS-associated phenotypes like altered vocalizations, social behavior, EEG abnormalities, and motor deficits.

Conclusions:

  • Common marmosets with FMR1 mutations serve as a valuable translational model for FXS.
  • Female marmosets heterozygous for the FMR1 mutation are particularly promising for studying FXS mechanisms and therapeutic strategies.